RheumPAC, the ACR’s political action committee (PAC), is tasked with fundraising, vetting legislators, participating in Capitol Hill visits and developing important relationships for the College. During my interview with Gary Bryant, MD, the ACR’s inaugural RheumPAC chair, he shared his thoughts on the role of rheumatology advocacy in advancing clinical practice, research and education.
ACR@Work: Have you always been interested in advocacy?
Dr. Bryant: I am a longtime ACR member having joined the College before my fellowship. I began my advocacy efforts locally as a Wisconsin state delegate to the State Medical Society of Wisconsin House of Delegates and then as a board member Wisconsin State Medical Society,focusing on government affairs. Shortly thereafter, I was invited to join the ACR CORC [Committee on Rheumatologic Care], and that launched my career in rheumatology advocacy. In addition, for 17 years, I have been one of the ACR delegates to the American Medical Association [AMA]. The synergy between the AMA and the ACR on issues relevant to rheumatology is an important aspect of our advocacy efforts.
ACR@Work: What challenges did you face leading the first RheumPAC?| | | Next → | Single Page